COVID-19 severity prediction in patients with chronic hepatitis C depending on the liver fibrosis stage

QR Code

COVID-19 severity prediction in patients with chronic hepatitis C depending on the liver fibrosis stage

The aim of the study was to develop a method for assessing the risk of severity of the novel coronavirus infection COVID-19 in patients with chronic hepatitis C depending on the severity of liver fibrosis.Object and methods. The results of laboratory data of patients with COVID-19 and chronic hepati...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. N. Temnik, D. Yu. Konstantinov, L. L. Popova, N. P. Persteneva
Format:	Article
Language:	Russian
Published:	Private institution educational organization of higher education "Medical University "ReaViz" 2024-06-01
Series:	Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье
Subjects:	covid-19 chronic hepatitis c prognosis of severity computer program
Online Access:	https://vestnik.reaviz.ru/jour/article/view/957
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Characteristics of lipid metabolism disorders in patients with coronavirus infection-COVID-19 with chronic hepatitis C
by: E. I. Temnik, et al.
Published: (2023-11-01)

Adiponectin level and severity of liver fibrosis in patients chronic hepatitis C with metabolic syndrome
by: A. F. Novikova, et al.
Published: (2018-07-01)

Polymorphism of renin — angiotensin system genes in progression of liver fibrosis in patients with chronic hepatitis C
by: O. V. Taratina, et al.
Published: (2014-08-01)

Liver cirrhosis as a result of chronic hepatitis C
by: A. A. Sukhoruk, et al.
Published: (2014-09-01)

Characteristics of Hepatitis C Epidemic Process in the Republic of Belarus
by: V. S. Vysotskaya, et al.
Published: (2021-01-01)

Detection rate of specific antibodies to the HCV CORE+1 protein in “naive” cronically HCV-infected patients in depends on the stage of liver fibrosis and the HCV subtype
by: E. V. Lichnaya, et al.
Published: (2021-01-01)

COST-EFFECTIVENESS OF ANTIVIRAL THERAPY IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C (GENOTYPE 1) WITH VARIOUS SEVERITY OF FIBROSIS STAGE
by: A. V. Rudakova, et al.
Published: (2018-01-01)

Сomparative morphological characteristics of activity score and fibrosis stage in chronic viral hepatitis C
by: I. L. Purlik, et al.
Published: (2010-10-01)

Predict of the development of lipid distress syndrome in patients with a sustained response to antiviral therapy of chronic hepatitis C
by: D. Yu. Konstantinov, et al.
Published: (2019-12-01)

INCIDENCE OF AUTOANTIBODIES IN PATIENTS WITH AUTOIMMUNE LIVER DISEASES AND CHRONIC HEPATITIS C
by: K. L. Raikhelson, et al.
Published: (2014-07-01)

Liver fibrosis assessment by transient elastography in patients with liver cirrhosis after hepatitis C virus eradication
by: E. A. Nabatchikova, et al.
Published: (2020-03-01)

Liver CT Perfusion Imaging as a Non-Invasive Method for Assessing Hemodynamics of the Hepatic Parenchyma in Patients with Fibrosis and Cirrhosis as a Result of Chronic Viral Hepatitis C
by: G. A. Stashuk, et al.
Published: (2022-02-01)

Clinical and epidemiological characteristic of chronic hepatitis C in the republic of Tyva
by: A. A. Saryglar, et al.
Published: (2023-04-01)

Long-Term Monitoring of Liver Fibrosis and Steatosis in Patients with Chronic Hepatitis C after Achieving a Sustained Virologic Response to Antiviral Therapy
by: K. R. Dudina, et al.
Published: (2023-02-01)

Genotypic Diversity of Hepatitis C Virus in Tuberculosis Patients in the Tomsk Region
by: K. A. Svirin, et al.
Published: (2025-03-01)

Application of dicarbamin in treatment of patients by a chronic hepatitis C
by: D. Yu. Konstantinov, et al.
Published: (2011-09-01)

Cryoglobulinemia and hepatitis C virus
by: N. V. Dunaeva, et al.
Published: (2014-09-01)

The use of sofosbuvir for the treatment of recurrent hepatitis C after liver transplantation
by: M. Sh. Khubutiya, et al.
Published: (2017-03-01)

Clinical and laboratory characteristics of chronic hepatitis C on the early stages of development
by: N. S. Zhevnerova, et al.
Published: (2016-12-01)

CHEMOKINES AND THEIR RECEPTORS EXPRESSION IN BLOOD AND LIVER TISSUE IN CHRONIC HEPATITIS C
by: K. V. Zhdanov, et al.
Published: (2014-07-01)

Cycloferon Therapy of Acute and Chronic Virus Hepatitis C
by: V. P. Malyy, et al.
Published: (2020-05-01)

Liver graft dysfunction due to hepatitis C infection
by: V. E. Syutkin, et al.
Published: (2018-08-01)

TUMOR NECROSIS AND TRANSFORMING GROWTH FACTORS LEVEL IN SUB-CLINICAL STAGE OF CHRONIC HEPATITIS C
by: T. V. Antonova, et al.
Published: (2014-07-01)

Clinical and morphological variants of hepatitis onset with congenital cytomegalovirus and hepatitis C infection
by: R. A. Ushakova, et al.
Published: (2014-09-01)

Expression of bcl-2 in the liver tissue of patients with autoimmune liver diseases and chronic hepatitis C
by: K. L. Raykhel`son, et al.
Published: (2014-09-01)

Infección por hepatitis C: Enfoque para dermatólogos
by: Ximena Hormaza
Published: (2003-06-01)

TREATMENT OF HEPATITIS C WITHOUT INTERFERON IN PATIENTS UNDERGOING LIVER TRANSPLANTATION
by: M. Sh. Khubutia, et al.
Published: (2015-10-01)

SOLUBLE FORMS OF MEMBRANOUS ANTIGENS IN SERUM OF PATIENTS WITH HEPATITIS C
by: T. V. Vishnevskaya, et al.
Published: (2014-07-01)

Effects of antiviral therapy on reducing the risk of metabolic syndrome in patients with chronic hepatitis C
by: A. F. Novikova, et al.
Published: (2023-07-01)

DETECTION OF HEPATITIS C VIRUS-SPECIFIC REPLICATION MARKERS IN PERIPHERAL BLOOD MONONUCLEARS FROM THE PATIENTS WITH CHRONIC HEPATITIS C
by: T. V. Vishnevskaya, et al.
Published: (2014-07-01)

Genetic polymorphism of hepatitis C virus and risk of hepatocellular carcinoma
by: S. N. Mammayev, et al.
Published: (2014-09-01)

Liver injury under chronic viral hepatitis C against the background of opiomania: morphological characters
by: Ye. V. Beloborodova, et al.
Published: (2011-02-01)

Validation of transient elastography cut-points for assessing the stage of liver fibrosis in children
by: E. A. Kulebina, et al.
Published: (2021-06-01)

REAL-TIME ELASTOGRAPHY AND ITS CLINICAL APPLICATION COMPARED WITH OTHER METHODS FOR EVALUATION OF THE LIVER FIBROSIS DEGREE IN PATIENTS WITH CHRONIC HEPATITIS C
by: M. A. Belopolskaya, et al.
Published: (2018-10-01)

Factors Associated with Hepatitis B and Hepatitis C among Infected Patients in Indonesia and Their Knowledge and Attitude: A Multicenter Observational Study
by: Juferdy Kurniawan, et al.
Published: (2024-07-01)

Betaleukin in therapy of chronic hepatitis C
by: E. S. Romanova, et al.
Published: (2014-10-01)

Cytokine profiling of plasma in patients with viral hepatitis C
by: N. A. Arsentieva, et al.
Published: (2024-11-01)

Russian interferon <i>α</i>-2b drug in the treatment of chronic hepatitis C
by: N. B. Kovaleva
Published: (2014-08-01)

POSSIBILITIES OF HEPATITIS C ANTIVIRAL TREATMENT IN LIVER TRANSPLANT RECIPIENTS
by: V. E. Syutkin, et al.
Published: (2011-06-01)

Bridging viral hepatitis and liver cancer: Emerging concepts in pathogenesis and therapeutic innovation
by: Keyin Zheng, et al.
Published: (2025-06-01)